Antimicrobial resistance markers distribution in Staphylococcus aureus from Nsukka, Nigeria.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 12 11 2023
accepted: 12 02 2024
medline: 18 3 2024
pubmed: 16 3 2024
entrez: 16 3 2024
Statut: epublish

Résumé

Multidrug resistance in Staphylococcus aureus continues to influence treatment complications in clinical settings globally. Multidrug-resistant-S. aureus (MDR-SA) is often genetically driven by resistance markers transferable in pathogenic strains. This study aimed to determine the distribution of resistance markers in clinical isolates of S. aureus in Nsukka, Nigeria. A total of 154 clinical samples were cultured on mannitol salt agar. Isolates were characterized using conventional cultural techniques and confirmed by PCR detection of S. aureus-specific nuc gene. Antibiotic resistance profiles of the isolates were determined against selected antibiotics using the disk-diffusion method, while screening for antibiotic resistance genes (Mec A, Erm A, Erm B, Erm C, Van A, and Van B) was by PCR. A total of 98 isolates were identified as S. aureus by conventional methods. Of these, 70 (71.43%) were confirmed by PCR. Phenotypically, the isolates exhibited high degrees of resistance to oxacillin (95.72%), erythromycin (81.63%), and ertapenem (78.57%) and 75.51% and 47.30% against methicillin and vancomycin, respectively. Multiple antibiotic resistance indexes of the isolates ranged from 0.3 to 1, and the most prevalent pattern of resistance was oxacillin-ertapenem-vancomycin-erythromycin-azithromycin-clarithromycin-ciprofloxacin- cefoxitin-amoxicillin-clavulanic acid. PCR screening confirmed the existence of various antibiotic resistance makers among the strains, with the most common resistance genes found in the isolates being Mec A (32.14%), Van A (21.43%), Van B (10.71%), Erm B (10.71%), and Erm C (17.86%). None possessed the Erm A gene. The study supports the need for necessary action, including rational drug use, continuous surveillance, and deployment of adequate preventive and curative policies and actions.

Sections du résumé

BACKGROUND BACKGROUND
Multidrug resistance in Staphylococcus aureus continues to influence treatment complications in clinical settings globally. Multidrug-resistant-S. aureus (MDR-SA) is often genetically driven by resistance markers transferable in pathogenic strains. This study aimed to determine the distribution of resistance markers in clinical isolates of S. aureus in Nsukka, Nigeria.
METHODS METHODS
A total of 154 clinical samples were cultured on mannitol salt agar. Isolates were characterized using conventional cultural techniques and confirmed by PCR detection of S. aureus-specific nuc gene. Antibiotic resistance profiles of the isolates were determined against selected antibiotics using the disk-diffusion method, while screening for antibiotic resistance genes (Mec A, Erm A, Erm B, Erm C, Van A, and Van B) was by PCR.
RESULTS RESULTS
A total of 98 isolates were identified as S. aureus by conventional methods. Of these, 70 (71.43%) were confirmed by PCR. Phenotypically, the isolates exhibited high degrees of resistance to oxacillin (95.72%), erythromycin (81.63%), and ertapenem (78.57%) and 75.51% and 47.30% against methicillin and vancomycin, respectively. Multiple antibiotic resistance indexes of the isolates ranged from 0.3 to 1, and the most prevalent pattern of resistance was oxacillin-ertapenem-vancomycin-erythromycin-azithromycin-clarithromycin-ciprofloxacin- cefoxitin-amoxicillin-clavulanic acid. PCR screening confirmed the existence of various antibiotic resistance makers among the strains, with the most common resistance genes found in the isolates being Mec A (32.14%), Van A (21.43%), Van B (10.71%), Erm B (10.71%), and Erm C (17.86%). None possessed the Erm A gene.
CONCLUSION CONCLUSIONS
The study supports the need for necessary action, including rational drug use, continuous surveillance, and deployment of adequate preventive and curative policies and actions.

Identifiants

pubmed: 38491352
doi: 10.1186/s12879-024-09126-1
pii: 10.1186/s12879-024-09126-1
doi:

Substances chimiques

Anti-Bacterial Agents 0
Vancomycin 6Q205EH1VU
Ertapenem G32F6EID2H
Oxacillin UH95VD7V76
Erythromycin 63937KV33D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

320

Informations de copyright

© 2024. The Author(s).

Références

World Health Organization. Antimicrobial Resistance. 2021. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance . Accessed 27 June 2022.
Financial Times Limited. Antibiotic resistance in Africa: ‘a pandemic that is already here’. Available from: https://www.ft.com/content/95f150df-5ce6-43cf-aa8d-01ac3bdcf0ef ; Accessed 26: 2022.
Ndihokubwayo JB, Yahaya AH, Desta AT, Ki-Zerbo G, Odei EA, Keita B, et al. Antimicrobial resistance in the African Region: issues, challenges and actions proposed. Volume 16. WHO Regional Office for Africa; 2013. pp. 27–30.
Tadesse BT, Ashley EA, Ongarello S, Havumaki J, Wijegoonewardena M, González IJ, et al. Antimicrob Resist Africa: Syst Rev BMC Infect Dis. 2017;17:616.
Saleem N, Nawaz M, Ghafoor A, Javeed A, Mustafa A, Yousuf MR, et al. Phenotypic and Molecular Analysis of Antibiotic Resistance in Lactobacilli of Poultry origin from Lahore, Pakistan. Pak Vet J. 2018;38(4):409–13.
doi: 10.29261/pakvetj/2018.084
Chen CJ, Huang YC. New epidemiology of Staphylococcus aureus infection in Asia. Clin Microbiol Infect. 2014;20:605–23.
doi: 10.1111/1469-0691.12705 pubmed: 24888414
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestation, and management. Clin Microbiol Rev. 2015;28:603–11.
doi: 10.1128/CMR.00134-14 pubmed: 26016486 pmcid: 4451395
Kandemir O, Oztuna V, Colak M, Akdag A, Camdeviren H. Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin–resistant Staphylococcus aureus osteomyelitis mode. J Chemother. 2008;20:53–7.
doi: 10.1179/joc.2008.20.1.53 pubmed: 18343744
McGuinness WA, Malachowa N, Deleo FR. Vancomycin resistance in Staphylococcus aureus. J Bio Med. 2017;90(2):269–81.
Anjum MF, Zankari E, Hasman H. 2017. Molecular methods for detection of antimicrobial resistance. M. Spect. 2017; 5(6). https://doi.org/10.1128/microbiolspec.ARBA-0011-2017 .
Shekarabi M, Hajikhani B, Chirani AS, Fazeli M, Goudari M. Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: a three year study in Tehran, Iran. PLoS ONE. 2017;12(8):e0183607. https://doi.org/10.1371/journal.pone.0183607 .
doi: 10.1371/journal.pone.0183607 pubmed: 28854219 pmcid: 5576738
Al-Amery K, Elhariri M, Elsayed A, EI-Moghazy G, Elhelw R, EI-Mahallawy H, et al. Vancomycin-resistant Staphylococcus aureus isolated from Camel meat and slaughterhouse workers in Egypt. Antimicrob Resist Infect Control. 2019;8:129: 2–8.
doi: 10.1186/s13756-019-0585-4
Micheal DE, Goodyear, Karmela Krleza-Jeric. The declaration of Helsinku. BMJ. 2007;335:626. https://doi.org/10.1136/bmj.39339.610000.BE .
doi: 10.1136/bmj.39339.610000.BE
Goudarzi M, Seyedjavadi SS, Nasiri MJ, Goudarzi H, Nia RS, Dabiri H. Molecular characterization of Methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bacteraemia based on MLS, SCCmec,Spa, and agr locus type analysis. Microb Pathog. 2017;104:328–35.
doi: 10.1016/j.micpath.2017.01.055 pubmed: 28159661
CLSI., Performance Standards for antimicrobial Susceptibility testing: CLSI Supplement M100S; Clinical and Laboratory Standards Institute Wayne, PA, USA. 2016.
CLSI., Performance Standards for antimicrobial Susceptibility testing: CLSI Supplement M100S; Clinical and Laboratory Standards Institute Wayne, PA, USA. 2018.
Katvoravutthichai C, Boonbumrung K, Tiyawisutsri R. Prevalence of β lactamase classes a,C and D among clinical isolates of P. Aeruginosa from a tertiary-level hospital in Bangkok. Thailanh Gen Mol Res. 2016;15(3). https://doi.org/10.4238/gmr.15038706 .
Agbo MC, Ugwu KO, Ukwah BN, Ezeonu IM. Molecular characterization of multidrug resistant (MDR) clinical isolates of Pseudomonas aeruginosa from Nsukka, South Eastern Nigeria. Afri Health Sci. 2023;23(3):497–505. https://doi.org/10.4314/ahs.v23i3.57 .
doi: 10.4314/ahs.v23i3.57
Strommenger B, Kettlitz C, Werner G, Witte W. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol. 2003;41(9):4089–94.
doi: 10.1128/JCM.41.9.4089-4094.2003 pubmed: 12958230 pmcid: 193808
Aziman A, Havaei SA, Fazeli H, Naderi M, Ghazvini K, Samiee SM, et al. Genetic characterization of a Vancomycin-resistant Staphylococcus aureus isolates from the respiratory tract of a patient in a University hospital in North eastern Iran. J Clin Microbiol. 2012;50(11):3581–5.
doi: 10.1128/JCM.01727-12
Saadat S, solhjoo K, Norooz-Nejad MJ, Kazemi A. VanA and VanB positive Vancomycin-resistant S. aureus among clinical isolates in Shiraz, South of Iran. Oman Med J. 2014;29:335.
doi: 10.5001/omj.2014.90 pubmed: 25337309 pmcid: 4202220
Goudarzi GR, Tahmasbi F, Anbari K, Ghafarzadeh M. The prevalence of Macrolide-resistant genes among Staphylococci isolated from the nasal cavity of hospital employees in Khorrramabad, Iran. Iran Red. Cres Med J. 2016;18(2):e25701.
Khoshnood S, Shahi F, Jomehzadeh N, Montazeri EA, Saki M, Mortazavi SM, et al. Distribution of genes encoding resistance to Macrolides, Lincosamides, and Streptogramins among Methicillin–resistant Staphylococcus aureus strains isolated from burn patients. Acta Microbiol et Immunoloica Hungarica. 2019;66(3):387–98.
doi: 10.1556/030.66.2019.015
Maalik A, Ali S, Anam Iftikhar MR, Ahmad H, Khan I. Prevalence and antibiotic resistance of Staphylococcus aureus and Risk factors for bovine subclinical mastitis in District Kasur, Punjab, Pakistan. Pak J Zoo. 2019;51:1123–30.
doi: 10.17582/journal.pjz/2019.51.3.1123.1130
Deyno S, Fekadu S, Astatkie A. Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis. Anti Resist Infect Con. 2017;6:85. https://doi.org/10.1186/s13756-017-0243-7 .
doi: 10.1186/s13756-017-0243-7
Khanal LK, Jha BK. Prevalence of methicillin-resistant S. Aureus (MRSA) among skin infection cases at a hospital in Chitwai, Nepal. Nepal Med Coll J. 2010;12(4):224–8.
pubmed: 21744763
Rossato AM, Primon-Barros M, Rocha L, Reiter KC, Dias CAG. Alves D’ Azevedo P. Resistance profile to antimicrobials agents in methicillin-resistant S. Aureus isolated from hospitals in South Brazil between 2014–2019. J Braz Soc Trop Med. 2020;53(e2020431):1–10.
Sharama C, Rokana N, Chandra M, Singh BP, Gullhance RD, Gill TPS, et al. Antimicrobial resistance: its Surveillance, Impact and Alternative Management strategies in dairy animals. Front Vet Sci. 2018;237(4):1–27.
Baddour MM, AbuEIheir MM, Fatani AJ. Comparison of mecA polymerase chain reaction with phenotypic methods for the detection of methicillin-resistant S. Aureus Curr. Microbiol. 2007;55:473–9.
Scholtzek AD, hanke D, Walther B, Eichhorn I, Stöckle SD, Klein KS et al. Molecular Characterization of Equine Staphylococcus aureus isolates Exhibiting Reduced Oxacillin Susceptibility. Toxins.2019; 11(9) 535 https://doi.org/10.3390/toxins11090535 .
Pournajaf A, Ardebili A, Goudarzi L, Khodabandeh M, Narimani T, Abbazadeh H. PCR-based identification of methicillin-resistant S. aureus strains and their antibiotic resistance profiles. Asi Pacif J Tropic Biomed. 2014;4(suppl 1):293–S297.
doi: 10.12980/APJTB.4.2014C423
Alghizzi M, Alansari M, Shami A. The prevalence of S. Aureus and Methicillin Resistant S. Aureus in processed food samples in Riyadh, Saudi Arabia. J Pure Appl Microbiol. 2021;15(1):91–9.
doi: 10.22207/JPAM.15.1.03
Khashesi R, Malekzadegan Y, Ebrahim-Saraie HS, Razavi Z. Phenotypic and genotypic characterization of Macrolide, Lincosamide and Streptogramin B resistance among clinical isolates of Staphylococci in Southwest of Iran. BMC Res note. 2018;11:711.
doi: 10.1186/s13104-018-3817-4
Razeghi M, Saffarian P, Goudarzi M. Incidence of inducible clindamycin resistance and antibacterial resistance genes variability in clinical S. aureus strains: a two- year multicentre study in Tehran Iran. Gen Rep. 2019;16:100411.
Fasihi Y, Saffari F, Kandehkar Ghahraman MRK. Kalantar–Neyestanaki D. Molecular detection of Macrolide and Lincosamide– Resistance genes in clinical methicillin-resistant Staphylococcus aureus isolates from Kerman. Iran Arch Pediatr Infect Dis. 2017;5:e37761.
Faccone D, Togneri AM, Podesta L, Perez M, Gagetti P, Sanchez S, et al. MRSA paediatric clone expressing ermC Plus LnuA genes causing nosocomial transmission and healthcare workers colonization in a neonatal intensive care unit. Infect Genet Evol. 2014;25:78–80.
doi: 10.1016/j.meegid.2014.04.005 pubmed: 24747609
Tunkei AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–84.
doi: 10.1086/425368
Karasin G, Bayram Y, Parlak M, Aypak C, Akgül M. Güdücüoğlu the evaluation of Vancomycin–resistant enterococci and carbapenemase producing Klebsiella colonization among ICU– hospitalized patients. Afri Health Scs. 2021;21(4):1662–8.
doi: 10.4314/ahs.v21i4.20
Sarrou S, Malli E, Tsili pounidaki K, Florou Z, Medvecky M, Skoulakis A, et al. MLSB resistant S. aureus in central Greece: rate of resistance and molecular characterization. Microb Drug Res. 2019;25(4):543–50.
doi: 10.1089/mdr.2018.0259
Pekana A, Green E. Antimicrobial Resistance profiles of S. Aureus isolated from meat carcasses and Bovine milk in abattoirs and dairy farm of the Eastern Cape, South Africa. Int J Environ Res Public Health. 2018;15:2223.
doi: 10.3390/ijerph15102223 pubmed: 30314300 pmcid: 6210798
Gao J, Ferreri M, Liu XQ, Chen IB, Su JI, Han B. Development of Multiplex polymerase chain reaction assay for rapid detection of S. Aureus and selected antibiotic resistance genes in bovine mastitis milk samples. J Vet Diagn Investig. 2011;23:894–901.
doi: 10.1177/1040638711416964
Yang F, Wang Q, Wang XR, Wang L, Li X-P, Luo J, et al. Genetic characterization of antimicrobial resistance in S. Aureus isolated from bovine mastitis cases in North West China. J Integr Agric. 2016;15:2542–847.
doi: 10.1016/S2095-3119(16)61368-0
Frey Y, Rodriguez JP, Thomann A, Schwendener S, Perreten V. Genetic characterization of antimicrobial resistance in coagulase-negative Staphylococci from bovine mastitis milk. J Dairy Sci. 2013;96:2247–57.
doi: 10.3168/jds.2012-6091 pubmed: 23415536

Auteurs

Martina C Agbo (MC)

Department of Pharmaceutical Microbiology and Biotechnology, University of Nigeria, Nsukka, Nigeria. martina.agbo@unn.edu.ng.

Ifeoma M Ezeonu (IM)

Department of Microbiology, University of Nigeria, Nsukka, Nigeria.

Beatrice O Onodagu (BO)

Microbiology Laboratory Unit, University of Nigeria Teaching Hospital, Enugu, Nigeria.

Chukwuemeka C Ezeh (CC)

Department of Microbiology, University of Nigeria, Nsukka, Nigeria.

Chizoba A Ozioko (CA)

Department of Pharmaceutical Microbiology and Biotechnology, University of Nigeria, Nsukka, Nigeria.

Stephen C Emencheta (SC)

Department of Pharmaceutical Microbiology and Biotechnology, University of Nigeria, Nsukka, Nigeria. stephen.emencheta@unn.edu.ng.
VBlab-Laboratory of Bacterial Viruses, University of Sorocaba, 18023-000, Sorocaba, SP, Brazil. stephen.emencheta@unn.edu.ng.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH